Ozempic Slows Kidney Disease, Novo Nordisk Study Finds

Novo Nordisk’s Ozempic drug slows the progression of chronic kidney disease and cuts the risk of kidney failure, heart attack, stroke and death in patients with Type 2 diabetes, a long-term trial showed.